REGN fundamentals
An in-depth look to Regeneron Pharmaceuticals, Inc. operating, investing, and financing activities
REGN free cash flow for Q1 24 is 1.38 B USD. For 2023, REGN free cash flow was 3.88 B USD and operating cash flow was 4.59 B USD.
Q3 '22
Q4 '22
Q1 '23
Q2 '23
Q3 '23
Q4 '23
Q1 '24
0.00
Cash from operating activities
Cash from investing activities
Cash from financing activities
Currency: USD
Q3 '22
Q4 '22
Q1 '23
Q2 '23
Q3 '23
Q4 '23
Q1 '24
TTM